Herbal nephropathy – a serious condition based on the innocence of nature
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.012Keywords
nephropathy, traditional medicine, herbAbstract
Introduction and purpose: This study aimed to discuss herbal supplement usage in population and possible harmful effects with a strong emphasis on the kidneys health.
Materials and methods: A literature search was conducted in the PubMed MEADLINE database of medical publications using the following keywords: herbal nephropathy, aristolochic nephropathy, herbal supplementation, Chinese traditional medicine
Results: Despite the widespread use of herbs among the general public, awareness of possible side effects appears to be negligible. The herbal medicine market is often unregulated, moreover, there are problems with correct identification of the plant, variable cultivation, its processing and the lack of accurate information about its biological activity. Possible side effects include frequent contamination of preparations with heavy metals, other substances such as hormones, aflatoxins or pesticides. In addition, herbs can directly affect the metabolism of drugs taken for specific medical indications. They are able to change the level of their absorption, metabolism in the liver and secretion. The kidneys are a special organ exposed to the harmful effects of herbs due to their high blood flow, resorption from the renal tubules and high metabolic activity. Among kidney damage, aristolochic nephropathy is the one worth mentioning, induced by the herb Aristolochia fangchi and causing a rapidly progressing kidney disease, largely ending up with the need for dialysis or kidney transplantation.
Conclusion: The use of herbs as medical substances carries dangers. They should be prevented through proper education of the society, appropriate legal regulations and doctors' awareness of their occurrence.
References
Granado RC del, Espinosa-Cuevas M. Herbal Nephropathy. Contrib Nephrol. 2021;199:143-154. doi:10.1159/000517693
Bagnis CI, Deray G, Baumelou A, le Quintrec M, Vanherweghem JL. Herbs and the kidney. American Journal of Kidney Diseases. 2004;44(1):1-11. doi:10.1053/j.ajkd.2004.02.009
Sci-Hub | Herbal remedies and clinical biochemistry. Annals of Clinical Biochemistry, 40(5), 489–507 | 10.1258/000456303322326407. Accessed August 27, 2022. https://sci-hub.se/10.1258/000456303322326407
Marcus DM, Grollman AP. Botanical Medicines — The Need for New Regulations. https://doi.org/101056/NEJMsb022858. 2002;347(25):2073-2076. doi:10.1056/NEJMSB022858
Efferth T, Kaina B. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab. 2011;12(10):989-996. doi:10.2174/138920011798062328
Ernst E, Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther. 2001;70(6):497-504. doi:10.1067/MCP.2001.120249
Lightfoote J, Blair HJ, Cohen JR. Lead Intoxication in an Adult Caused By Chinese Herbal Medication. JAMA. 1977;238(14):1539-1539. doi:10.1001/JAMA.1977.03280150109042
Karri SK, Saper RB, Kales SN. Lead Encephalopathy Due to Traditional Medicines. Curr Drug Saf. 2008;3(1):54. doi:10.2174/157488608783333907
Lin CC, Phua DH, Deng JF, Yang CC. Aconitine intoxication mimicking acute myocardial infarction. Hum Exp Toxicol. 2011;30(7):782-785. doi:10.1177/0960327110385960
Peng C, Zheng T, Yang F, Li YX, Zhang DK. Study of neurotoxic effects and underlying mechanisms of aconitine on cerebral cortex neuron cells. Arch Pharm Res. 2009;32(11):1533-1543. doi:10.1007/S12272-009-2105-1
Hu Z, Yang X, Ho PCL, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239-1282. doi:10.2165/00003495-200565090-00005
Evans V. Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use. J Neurosci Nurs. 2000;32(4):229-232. doi:10.1097/01376517-200008000-00007
Kiliś-Pstrusińska K, Wiela-Hojeńska A. Nephrotoxicity of Herbal Products in Europe-A Review of an Underestimated Problem. Int J Mol Sci. 2021;22(8). doi:10.3390/IJMS22084132
Kleinknecht D, Landais P, Goldfarb B. Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients. Adv Exp Med Biol. 1987;212:125-128. doi:10.1007/978-1-4684-8240-9_16
Jha V. Herbal medicines and chronic kidney disease. Nephrology (Carlton). 2010;15 Suppl 2(SUPPL. 2):10-17. doi:10.1111/J.1440-1797.2010.01305.X
Granado RC del, Espinosa-Cuevas M. Herbal Nephropathy. Contrib Nephrol. 2021;199:143-154. doi:10.1159/000517693
Akpan EE, Ekrikpo UE. Acute Renal Failure Induced by Chinese Herbal Medication in Nigeria. Case Rep Med. 2015;2015. doi:10.1155/2015/150204
Brown AC. Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 2017;107(Pt A):502-519. doi:10.1016/J.FCT.2016.07.024
BLAU JJ. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J Urol. 1998;160(3 Pt 1):825. doi:10.1097/00005392-199809010-00052
Powell T, Hsu FF, Turk J, Hruska K. Ma-Huang strikes again: Ephedrine nephrolithiasis. American Journal of Kidney Diseases. 1998;32(1):153-159. doi:10.1053/ajkd.1998.v32.pm9669437
Gabardi S, Munz K, Ulbricht C. A review of dietary supplement-induced renal dysfunction. Clin J Am Soc Nephrol. 2007;2(4):757-765. doi:10.2215/CJN.00500107
Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136(1):42-53. doi:10.7326/0003-4819-136-1-200201010-00010
Bolley R, Zulke C, Kammerl M, Fischereder M, Kramer BK. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John’s wort. Transplantation. 2002;73(6):1009. doi:10.1097/00007890-200203270-00035
Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341(8842):387-391. doi:10.1016/0140-6736(93)92984-2
Vanherweghem JL. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med. 1998;4(1):9-13. doi:10.1089/ACM.1998.4.1-9
Wu KM, Farrelly JG, Upton R, Chen J. Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine. 2007;14(4):273-279. doi:10.1016/J.PHYMED.2006.05.009
Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74(2):158-169. doi:10.1038/KI.2008.129
Cosyns JP. Aristolochic acid and “Chinese herbs nephropathy”: a review of the evidence to date. Drug Saf. 2003;26(1):33-48. doi:10.2165/00002018-200326010-00004
Luciano RL, Perazella MA. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf. 2015;38(1):55-64. doi:10.1007/S40264-014-0244-X
Wang SM, Lai MN, Wei A, et al. Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid. PLoS One. 2014;9(8):e105218. doi:10.1371/JOURNAL.PONE.0105218
Jadot I, Declèves AE, Nortier J, Caron N. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int J Mol Sci. 2017;18(2). doi:10.3390/IJMS18020297
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Iga Dudek, Natalia Rybak, Tomasz Skubel, Jakub Czarnota, Michał Dobrzyński, Małgorzata Drozd

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 436
Number of citations: 0